Cancer Medicine

Cancer

Sr. No. Medicine Name Drug Type / Purpose Frequency / Note
1. AB PHYLLINE SR 200 Asthma, COPD, bronchitis 200–400 mg BID
2. Abiraterone Prostate cancer (metastatic castration- resistant/sensitive) 1000 mg/day + prednisone
3. ANABREZ TAB Prostate cancer (bicalutamide) 50 mg once daily
4. AREDONET 90 MG Bone metastases (pamidronate) 90 mg IV every 4 weeks
5. ATCURON 10 MG INJ Muscle relaxation (atracurium) 0.5 mg/kg IV
6. Azacitidine MDS, AML, JMML 75 mg/m² SC/IV daily ×7 days (MDS) / 300 mg PO daily ×14 days (AML)
7. Bendamustine CLL, NHL 00 mg/m² IV (CLL) / 120 mg/m² IV (NHL)
8. Bortezomib Multiple myeloma, mantle cell lymphoma 1.3 mg/m² IV/SC (adjust for toxicity)
9. Busulfan Chronic myeloid leukemia, transplant conditioning 0.8 mg/kg IV every 6 hours ×4 days (transplant)
10. Cabazitaxel Prostate cancer (post-docetaxel) 20–25 mg/m² IV every 3 weeks + prednisone
11. Cabozantinib Thyroid cancer, renal cell carcinoma 20–60 mg once daily
12. Capecitabine Colorectal, breast cancer 250 mg/m² BID for 14 days (cycle-dependent)
13. Carmustine Brain tumors, Hodgkin’s lymphoma 150–200 mg/m² IV every 6 weeks
14. DARLONG TAB CML, ALL 100–140 mg once daily
15. Decitabine Myelodysplastic syndromes (MDS) 15–20 mg/m² IV daily ×3– 5 days
16. Dimethyl Fumarate Multiple sclerosis Start: 120 mg BID ×7 days → 240 mg BID
17. Enzalutamide Prostate cancer 160 mg once daily
18. Eribulin Metastatic breast cancer, liposarcoma 1.4 mg/m² IV on days 1 and 8 (21-day cycle)
19. Everolimus Renal/breast cancer, organ transplant 2.5–10 mg once daily
20. Fingolimod Multiple sclerosis 0.5 mg once daily
21. Fulvestrant Hormone receptor-positive breast cancer 500 mg IM monthly
22. IDROFOS 50 TAB Osteoporosis (ibandronate) 150 mg monthly or 3 mg IV every 3 months
23. IMALEK 400/TAB CML (imatinib) 400–800 mg daily
24. Lenalidomide Multiple myeloma, MDS cancer 5–25 mg daily ×21 days (28-day cycle)
25. Lenvatinib Thyroid cancer, hepatocellular carcinoma 24 mg once daily
26. LETROZ TAB Breast cancer (letrozole) 2.5 mg once daily
27. Liposomal Doxorubicin Ovarian cancer, Kaposi’s sarcoma 20–50 mg/m² IV every 2–4 weeks
28. Midostaurin Acute myeloid leukemia (AML) 50 mg BID with food
29. Nilotinib CML 300–400 mg BID
30. Nintedanib Idiopathic pulmonary fibrosis 150 mg BID
31. Olaparib Ovarian, breast, pancreatic cancer 300 mg BID
32. ONCOCARBIN AQ Chemotherapy (carboplatin) AUC-based dosing (e.g., AUC 5–6)
33. ONCOMOX 10 MG TAB Breast cancer (tamoxifen) 20 mg once daily
34. ONCTRON INJ Nausea/vomiting (ondansetron) 8 mg IV/PO pre-chemo
35. OXIPLAT TAB Colorectal cancer (oxaliplatin) 85–130 mg/m² IV every 2– 3 weeks
36. Palbociclib HR+/HER2- breast cancer 125 mg daily ×21 days (28- day cycle)
37. Palonosetron Chemotherapy-induced nausea/vomiting 0.25 mg IV ×1 pre-chemo
38. Pazopanib Renal cell carcinoma, soft tissue sarcoma 800 mg once daily
39. Pemetrexed Lung cancer, mesothelioma 500 mg/m² IV every 3 weeks
40. PILOMAX TAB Dry mouth (pilocarpine) 5 mg TID-QID
41. Plerixafor Stem cell mobilization 0.24 mg/kg SC daily (max 40 mg/day)
42. Sorafenib Liver, thyroid, renal cell carcinoma 400 mg BID
43. Sunitinib Malate Renal cell carcinoma, GIST 37.5–50 mg once daily
44. Venetoclax CLL, AML Ramp-up dosing (20→400 mg daily)

FOr any Kind Of queries Feel freE to contact us!

CALL NOW

Devsam Global Pharma Pvt Ltd

Devsam Global Pharma Pvt Ltd is a trusted name in the pharmaceutical industry, specializing in the export of high-quality medicines, chemicals, and herbal products to global markets. With a commitment to excellence, we ensure that all our products comply with international regulatory standards, delivering safe, effective, and reliable healthcare solutions worldwide.

Facebook X-twitter Linkedin

Quick Links

PRODUCTS Range

GET IN TOUCH